賽伍技術(603212.SH):蘇州金茂擬清倉減持不超4.54%的股份
格隆匯9月3日丨賽伍技術(603212.SH)公佈,截至公吿日,蘇州金茂新興產業創業投資企業(有限合夥)(“蘇州金茂”)持有公司無限售條件流通股1816.73萬股,佔公司總股本的4.54%;
蘇州金茂計劃自公吿披露之日起採取集中競價交易方式減持股份的,減持期間為自減持計劃公吿之日起15個交易日後的6個月內;採取大宗交易方式減持股份的,減持期間為自減持計劃公吿之日起3個交易日後的6個月內。擬減持股份數量和比例:蘇州金茂擬減持公司股份不超過1816.73萬股,即不超過公司總股本的4.54%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.